China healthcare: taking the private route

China healthcare: taking the private route

Our View - Issue V, December 2014

1000

Related content

China healthcare: taking the private route

China’s healthcare industry is facing inevitable change as it seeks to attract more foreign investment and encourage privatization of some public health facilities and services. In this issue, we outline the various reforms underway and how private capital is being used as an antidote to the nation’s overburdened healthcare system, in addition to the various options for investors.

© 2022 KPMG Huazhen LLP, a People's Republic of China partnership, KPMG Advisory (China) Limited, a limited liability company in Mainland China, KPMG, a Macau (SAR) partnership, and KPMG, a Hong Kong (SAR) partnership, are member firms of the KPMG global organisation of independent member firms affiliated with KPMG International Limited, a private English company limited by guarantee. All rights reserved.

The KPMG name and logo are trademarks used under license by the independent member firms of the KPMG global organisation.

For more detail about the structure of the KPMG global organisation please visit https://home.kpmg/governance.

京ICP备12028186号-1
京公网安备11010102003233号

Connect with us